Asymptomatic ovarian hemangioma in a postmenopausal patient with elevated estrogen

Ovarian hemangiomas are rare. Here, the authors report an asymptomatic ovarian hemangioma in a postmenopausal patient. Ultrasound revealed a left ovarian cyst measuring 2.06×1.74×2.11 cm in a 57-year-old postmenopausal female. On preoperative examination, estrogen and carbohydrate antigen 72-4 (CA72-4) were 131 pmol/L and 7.88 U/mL, respectively. The results of intraoperative frozen section examination and final histopathology were indicative of an ovarian hemangioma. This rare case of asymptomatic ovarian hemangioma with elevated estrogen might demonstrate a possible relationship between estrogen levels and ovarian hemangioma.

Ovarian hemangioma; Estrogen; CA72-4; Asymptomatic.

[1] Cormio G., Loverro G., Iacobellis M., Mei L., Selvaggi L.: “Hemangioma of the ovary. A case report”. J. Reprod. Med., 1998, 43, 459.

[2] Huang R.S., Covinsky M., Zhang S.: “Bilateral ovarian capillary hemangioma with stromal luteinization and hyperandrogenism”. Ann. Clin. Lab. Sci., 2013, 43, 457.

[3] Yamawaki T., Hirai Y., Takeshima N., Hasumi K.: “Ovarian hemangioma associated with concomitant stromal luteinization and ascites”. Gynecol. Oncol., 1996, 61, 438.

[4] Erdemoglu E., Kamaci M., Ozen S., Sahin H., Kolusari A.: “Ovarian hemangioma with elevated CA-125 and ascites mimicking ovarian cancer”. Eur. J. Gyneacol. Oncol., 2006, 27, 195.

[5] Itoh H., Wada T., Michikata K., Sato Y., Seguchi T., Akiyama Y., et al.: “Ovarian teratoma showing a predominant hemangiomatous element with stromal luteinization: report of a case and review of the literature”. Pathol. Int., 2004, 54, 279.

[6] Prus D., Rosenberg A.E., Blumenfeld A., Udassin R., Ne’eman Z., Young R.H., et al.: “Infantile hemangioendothelioma of the ovary: A monodermal teratoma or a neoplasm of ovarian somatic cells?” Am. J. Surg. Pathol., 1997, 21, 1231.

[7] Comunoglu C., Atasoy L., Baykal C.: “Ovarian hemangioma occurring synchronously with contralateral mature cystic teratoma in an 81-year-old patient”. Ups. J. Med. Sci., 2010, 115, 297.

[8] Savargaonkar P., Wells S., Graham I., Buckley C.: “Ovarian haemangiomas and stromal luteinization”. Histopathology, 1994, 25, 185.

[9] Carder P., Gouldesbrough D.: “Ovarian haemangiomas and stromal luteinization”. Histopathology, 1995, 26, 585.

[10] Miliaras D., Papaemmanouil S., Blatzas G.: “Ovarian capillary hemangioma and stromal luteinization: a case study with hormonal receptor evaluation”. Eur. J. Gynaecol. Oncol., 2001, 22, 369.

[11] Gücer F., Ozyilmaz F., Balkanli-Kaplan P., Mülayim N., Aydin O.: “Ovarian hemangioma presenting with hyperandrogenism and endometrial cancer: a case report”. Gynecol. Oncol., 2004, 94, 821.

[12] Anand M.S., Shetty S., Mysorekar V.V., Kumar R.V.: “Ovarian hemangioma with stromal luteinization and HCG-producing mononucleate and multinucleate cells of uncertain histogenesis: a rare co-existence with therapeutic dilemma”. Indian J. Pathol. Microbiol., 2012, 55, 509.

[13] Nezhat F., Slomovitz B.M., Saiz A.D., Cohen C.J.: “Ovarian mucinous cystadenocarcinoma with virilization”. Gynecol. Oncol., 2002, 84, 468.

[14] Schoolmeester J.K., Greipp P.T., Keeney G.L., Soslow R.A.: “Ovarian Hemangiomas Do Not Harbor EWSR1 Rearrangements: Clinicopathologic Characterization of 10 Cases”. Int. J. Gynecol. Pathol., 2015, 34, 437.

[15] Sun Z.Y., Yang L., Yi C.G., Zhao H., Han D.L., Yang T., et al.: “Possibilities and potential roles of estrogen in the pathogenesis of proliferation hemangiomas formation”. Med. Hypotheses, 2008, 71, 286.